Duke-Margolis Monthly Health Policy Updates

Press Release: A Path For FDA, Consumers Toward More Effective Drug Safety Labeling

WASHINGTON, D.C. -- Changes by the Food and Drug Administration (FDA) to drug safety labeling are an important way to provide patients and providers with the most up-to-date information about a product’s risk.

WASHINGTON, D.C. -- Changes by the Food and Drug Administration (FDA) to drug safety labeling are an...

Former Commissioners Call for FDA to Become Independent Federal Agency

In a commentary published in Health Affairs, seven former FDA Commissioners call for the FDA to evolve into an independent federal agency in order to better support its core missions, foster efficiency, and remove administrative roadblocks.

In a commentary published in Health Affairs, seven former FDA Commissioners call for the FDA to...

The FDA Sentinel Initiative — An Evolving National Resource

Duke-Margolis Center Director Mark McCellan, MD, PhD, co-authored a New England Journal of Medicine Perspective on the evolution and impact of the FDA’s Sentinel Network in the November 29 issue.

Duke-Margolis Center Director Mark McCellan, MD, PhD, co-authored a New England Journal of Medicine...